Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer

Sponsor
Royal Marsden NHS Foundation Trust
Study ID
NCT00004237
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • cyclophosphamide — DRUG
  • doxorubicin hydrochloride — DRUG
  • epirubicin hydrochloride — DRUG
  • mitoxantrone hydrochloride — DRUG
  • vinorelbine tartrate — DRUG
  • conventional surgery — PROCEDURE
  • radiation therapy — RADIATION

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This randomized phase II trial is studying three regimens of combination chemotherapy to compare how well they work in treating women with stage I or stage II breast cancer.

Key Dates

Start date
Oct 31, 1998
Status verified
May 2005
Completion
Sep 30, 2005

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies